Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02376387 · ClinicalTrials.gov registry record
Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 4,333
- Enrollment target
NCT02376387: Completed study, sponsored by Stanford University.
NCT02376387 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 4,333 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02376387 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 4,333 participants
- Enrollment target
Study Summary
The proposed research will provide evidence-based strategies for the evaluation and acceptance of donor hearts for transplantation. This is relevant to public health because judicious expansion of donor hearts used for transplantation will make this life-saving procedure available to a larger number of patients living with end-stage heart disease.
Primary Outcome
To identify clinical correlates of cardiac function in potential donors being evaluated for heart transplantation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,333 participants |
| Start Date | 2015-03 |
| Est. Completion | 2020-05-26 |
What the finished NCT02376387 record still lists
NCT02376387 is an observational study that tracks outcomes without assigning an intervention. Its 4,333 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02376387 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02376387 about?
NCT02376387 is a clinical study titled "Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation". The proposed research will provide evidence-based strategies for the evaluation and acceptance of donor hearts for transplantation. This is relevant to public health because judicious expansion of donor hearts used for transplantation will make this life-saving procedure available to a larger number...
What is the current status of trial NCT02376387?
This trial is currently completed. The enrollment target is 4,333 participants. The study started on 2015-03. Estimated completion is 2020-05-26.
Who is sponsoring clinical trial NCT02376387?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia